Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Drain placement in thyroidectomy is associated with longer hospital stay without preventing hematoma.

Maroun CA, El Asmar M, Park SJ, El Asmar ML, Zhu G, Gourin CG, Fakhry C, Dhillon V, Tufano RP, Russell JO, Mandal R.

Laryngoscope. 2019 Sep 11. doi: 10.1002/lary.28269. [Epub ahead of print]

PMID:
31508818
2.

Association Between Hospital Market Concentration and Costs of Laryngectomy.

Gourin CG, Vosler PS, Mandal R, Pitman KT, Fakhry C, Eisele DW, Frick KD, Austin JM.

JAMA Otolaryngol Head Neck Surg. 2019 Aug 29. doi: 10.1001/jamaoto.2019.2303. [Epub ahead of print]

PMID:
31465102
3.

Correction to: On the reproducibility of expert-operated and robotic ultrasound acquisitions.

Kojcev R, Khakzar A, Fuerst B, Zettinig O, Fakhry C, DeJong R, Richmon J, Taylor R, Sinibaldi E, Navab N.

Int J Comput Assist Radiol Surg. 2019 Aug 20. doi: 10.1007/s11548-019-02055-4. [Epub ahead of print]

PMID:
31432359
4.

Evaluating the utility and prevalence of oral rinse and serologic HPV biomarkers for HPV-related oropharyngeal cancer.

D'Souza G, Clemens G, Troy T, Castillo RG, Struijk L, Waterboer T, Bender N, Pierorazio PM, Best SR, Strickler HD, Wiley DJ, Haddad RI, Posner M, Fakhry C.

Cancer Prev Res (Phila). 2019 Aug 16. pii: canprevres.0185.2019. doi: 10.1158/1940-6207.CAPR-19-0185. [Epub ahead of print]

PMID:
31420362
5.

Computed tomography performance in predicting extranodal extension in HPV-positive oropharynx cancer.

Faraji F, Aygun N, Coquia SF, Gourin CG, Tan M, Rooper LM, Eisele DW, Fakhry C.

Laryngoscope. 2019 Aug 14. doi: 10.1002/lary.28237. [Epub ahead of print]

PMID:
31411751
6.

Factors to Consider When Contemplating Posttreatment Surveillance for Survivors of HPV-Associated Oropharyngeal Squamous Cell Carcinoma.

Swegal WC, Eisele DW, Fakhry C.

JAMA Otolaryngol Head Neck Surg. 2019 Aug 8. doi: 10.1001/jamaoto.2019.1976. [Epub ahead of print] No abstract available.

PMID:
31393539
7.

Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment.

Windon MJ, Fakhry C, Faraji F, Troy T, Gourin CG, Kiess AP, Koch W, Eisele DW, D'Souza G.

Oral Oncol. 2019 Aug;95:11-15. doi: 10.1016/j.oraloncology.2019.05.016. Epub 2019 Jun 4.

PMID:
31345377
8.

Quality of care and short and long-term outcomes of oropharyngeal cancer care in the elderly.

Gourin CG, Herbert RJ, Quon H, Fakhry C, Kiess AP, Eisele DW, Frick KD.

Head Neck. 2019 Oct;41(10):3542-3550. doi: 10.1002/hed.25869. Epub 2019 Jul 11.

PMID:
31294878
9.

Tumor-infiltrating lymphocyte quantification stratifies early-stage human papillomavirus oropharynx cancer prognosis.

Faraji F, Fung N, Zaidi M, Gourin CC, Eisele DW, Rooper LM, Fakhry C.

Laryngoscope. 2019 May 9. doi: 10.1002/lary.28044. [Epub ahead of print]

PMID:
31070246
10.

Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Fakhry C, Blackford AL, Neuner G, Xiao W, Jiang B, Agrawal A, Gillison ML.

JAMA Oncol. 2019 Jul 1;5(7):985-992. doi: 10.1001/jamaoncol.2019.0439.

PMID:
31046104
11.

From presumed benign neck masses to delayed recognition of human papillomavirus-positive oropharyngeal cancer.

Davis RJ, Rettig E, Aygun N, Rooper L, D'Souza G, Eisele DW, Fakhry C.

Laryngoscope. 2019 Apr 5. doi: 10.1002/lary.27946. [Epub ahead of print]

PMID:
30950517
12.

Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.

Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT.

Cancer. 2019 Jun 15;125(12):2027-2038. doi: 10.1002/cncr.32025. Epub 2019 Mar 26.

PMID:
30913305
13.

The prognostic impact of pathologic lymph nodes in HPV-positive oropharyngeal cancers.

El Asmar M, Tsai HL, Fakhry C, Maroun CA, Mandal R, Pardoll DM, Wang H.

Oral Oncol. 2019 Feb;89:23-29. doi: 10.1016/j.oraloncology.2018.12.005. Epub 2018 Dec 15.

PMID:
30732954
14.

Tobacco Treatment Programs at National Cancer Institute-designated Cancer Centers: A Systematic Review and Online Audit.

Day AT, Tang L, Karam-Hage M, Fakhry C.

Am J Clin Oncol. 2019 Apr;42(4):407-410. doi: 10.1097/COC.0000000000000522.

PMID:
30724778
15.

Sex differences in HPV immunity among adults without cancer.

Windon MJ, Waterboer T, Hillel AT, Chien W, Best S, Stewart C, Akst L, Troy T, Bender N, Miles B, Ryan WR, Mandal R, Pitman K, Eisele DW, Fakhry C, D'Souza G.

Hum Vaccin Immunother. 2019;15(7-8):1935-1941. doi: 10.1080/21645515.2019.1568157. Epub 2019 Mar 19.

PMID:
30650013
16.

Priorities, concerns, and regret among patients with head and neck cancer.

Windon MJ, D'Souza G, Faraji F, Troy T, Koch WM, Gourin CG, Kiess AP, Pitman KT, Eisele DW, Fakhry C.

Cancer. 2019 Apr 15;125(8):1281-1289. doi: 10.1002/cncr.31920. Epub 2019 Jan 15.

PMID:
30645761
17.

The Impact of a Stepwise Approach to Primary Tumor Detection in Squamous Cell Carcinoma of the Neck With Unknown Primary.

Ryan JF, Motz KM, Rooper LM, Mydlarz WK, Quon H, Gourin CG, Tan M, Eisele DW, Fakhry C.

Laryngoscope. 2019 Jul;129(7):1610-1616. doi: 10.1002/lary.27625. Epub 2018 Nov 22.

PMID:
30565698
18.

The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.

Faraji F, Rettig EM, Tsai HL, El Asmar M, Fung N, Eisele DW, Fakhry C.

Cancer. 2019 Mar 1;125(5):761-769. doi: 10.1002/cncr.31841. Epub 2018 Dec 6.

PMID:
30521092
19.

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma.

Califano JA, Khan Z, Noonan KA, Rudraraju L, Zhang Z, Wang H, Goodman S, Gourin CG, Ha PK, Fakhry C, Saunders J, Levine M, Tang M, Neuner G, Richmon JD, Blanco R, Agrawal N, Koch WM, Marur S, Weed DT, Serafini P, Borrello I.

Clin Cancer Res. 2018 Dec 1;24(23):6100. doi: 10.1158/1078-0432.CCR-18-3298. No abstract available.

PMID:
30510089
20.

Association of Hospital Volume With Laryngectomy Outcomes in Patients With Larynx Cancer.

Gourin CG, Stewart CM, Frick KD, Fakhry C, Pitman KT, Eisele DW, Austin JM.

JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):62-70. doi: 10.1001/jamaoto.2018.2986.

PMID:
30476965
21.

Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.

Eytan DF, Blackford AL, Eisele DW, Fakhry C.

Cancer. 2019 Jan 15;125(2):249-260. doi: 10.1002/cncr.31800. Epub 2018 Nov 16.

PMID:
30444527
22.

Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

Windon MJ, D'Souza G, Fakhry C.

Future Oncol. 2018 Oct;14(24):2521-2530. doi: 10.2217/fon-2018-0063. Epub 2018 Sep 28. Review.

PMID:
30265132
23.

Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.

Eytan DF, Blackford AL, Eisele DW, Fakhry C.

Otolaryngol Head Neck Surg. 2019 Jan;160(1):85-92. doi: 10.1177/0194599818796163. Epub 2018 Sep 25.

PMID:
30252608
24.

In Regard to Bossi et al.

Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. No abstract available.

PMID:
30238902
25.

To kiss or not to kiss in the era of the human papillomavirus-associated head and neck cancer "epidemic"?

Rettig EM, Fakhry C, Nathan CO.

Laryngoscope. 2019 Jan;129(1):4-5. doi: 10.1002/lary.27277. Epub 2018 Sep 8. Review. No abstract available.

PMID:
30194848
26.

Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement Summary of the CAP Guideline.

Fakhry C, Lacchetti C, Perez-Ordonez B.

J Oncol Pract. 2018 Oct;14(10):613-617. doi: 10.1200/JOP.18.00433. Epub 2018 Sep 7. No abstract available. Erratum in: J Oncol Pract. 2019 Jan;15(1):60.

PMID:
30192693
27.

Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline.

Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, Bell D, Lingen MW, Harichand-Herdt S, Thibo J, Zevallos J, Perez-Ordonez B.

J Clin Oncol. 2018 Nov 1;36(31):3152-3161. doi: 10.1200/JCO.18.00684. Epub 2018 Sep 6. Erratum in: J Clin Oncol. 2019 Jan 20;37(3):261.

PMID:
30188786
28.

Effects of a Comprehensive Performance Improvement Strategy on Postoperative Adverse Events in Head and Neck Surgery.

Panuganti B, Qiu Y, Messing B, Lee G, Fakhry C, Blanco R, Ha P, Messer K, Califano JA.

Otolaryngol Head Neck Surg. 2019 May;160(5):799-809. doi: 10.1177/0194599818793887. Epub 2018 Aug 28.

PMID:
30149772
29.

Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.

Peng LC, Hui X, Cheng Z, Bowers MR, Moore J, Cecil E, Choflet A, Thompson A, Muse M, Kiess AP, Page BR, Gourin CG, Fakhry C, Szczesniak M, Maclean J, Wu P, Cook I, McNutt TR, Quon H.

Oral Oncol. 2018 Sep;84:25-30. doi: 10.1016/j.oraloncology.2018.05.012. Epub 2018 Jul 3.

PMID:
30115472
30.

Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.

Rettig EM, Zaidi M, Faraji F, Eisele DW, El Asmar M, Fung N, D'Souza G, Fakhry C.

Oral Oncol. 2018 Aug;83:147-153. doi: 10.1016/j.oraloncology.2018.06.013. Epub 2018 Jun 27.

31.

HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma.

Rettig EM, Bishop JA, Agrawal N, Chung CH, Sharma R, Zamuner F, Li RJ, Koch WM, Califano JA, Guo T, Gaykalova DA, Fakhry C.

Oral Oncol. 2018 Jul;82:168-175. doi: 10.1016/j.oraloncology.2018.05.017. Epub 2018 Jun 1.

PMID:
29909892
32.

P16 as a Prognostic Biomarker for Nonoropharyngeal Squamous Cell Cancers: Avatar or Mirage?

Fakhry C, Ferris RL.

J Natl Cancer Inst. 2018 Dec 1;110(12):1290-1291. doi: 10.1093/jnci/djy103. No abstract available.

PMID:
29878233
33.

Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.

Windon MJ, D'Souza G, Rettig EM, Westra WH, van Zante A, Wang SJ, Ryan WR, Mydlarz WK, Ha PK, Miles BA, Koch W, Gourin C, Eisele DW, Fakhry C.

Cancer. 2018 Jul 15;124(14):2993-2999. doi: 10.1002/cncr.31385. Epub 2018 Apr 30.

34.

Age Profile of Patients With Oropharyngeal Squamous Cell Carcinoma.

Rettig EM, Fakhry C, Khararjian A, Westra WH.

JAMA Otolaryngol Head Neck Surg. 2018 Jun 1;144(6):538-539. doi: 10.1001/jamaoto.2018.0310. No abstract available.

35.

Short- and long-term outcomes of oropharyngeal cancer care in the elderly.

Motz K, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Eisele DW, Koch WM, Frick KD, Gourin CG.

Laryngoscope. 2018 Sep;128(9):2084-2093. doi: 10.1002/lary.27153. Epub 2018 Mar 24.

PMID:
29573418
36.

Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy.

Rettig EM, Fakhry C, Hales RK, Kisuule F, Quon H, Kiess AP, Yin LX, Zhang Y, Blackford AL, Drummond MB, Gourin CG, Koch WM, Eisele DW, D'Souza G.

Head Neck. 2018 Jul;40(7):1534-1547. doi: 10.1002/hed.25148. Epub 2018 Mar 15.

37.

Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.

Yin LX, D'Souza G, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig EM, Ryan WR, Ha PK, Wentz A, Koch W, Eisele DW, Fakhry C.

Laryngoscope. 2018 Aug;128(8):E287-E295. doi: 10.1002/lary.27130. Epub 2018 Mar 14.

PMID:
29536542
38.

Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals.

Fakhry C, Krapcho M, Eisele DW, D'Souza G.

Cancer. 2018 May 15;124(10):2125-2133. doi: 10.1002/cncr.31322. Epub 2018 Mar 13.

39.

Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research.

Kreimer AR, Shiels MS, Fakhry C, Johansson M, Pawlita M, Brennan P, Hildesheim A, Waterboer T.

Cancer. 2018 May 1;124(9):1859-1866. doi: 10.1002/cncr.31256. Epub 2018 Mar 2. No abstract available.

40.

Evaluating oropharyngeal carcinoma with transcervical ultrasound, CT, and MRI.

Faraji F, Coquia SF, Wenderoth MB, Padilla ES, Blitz D, DeJong MR, Aygun N, Hamper UM, Fakhry C.

Oral Oncol. 2018 Mar;78:177-185. doi: 10.1016/j.oraloncology.2018.01.016. Epub 2018 Feb 20.

PMID:
29496048
41.

Bioinformatic Approach for Prediction of CsrA/RsmA-Regulating Small RNAs in Bacteria.

Fakhry CT, Zarringhalam K, Kulkarni RV.

Methods Mol Biol. 2018;1737:47-56. doi: 10.1007/978-1-4939-7634-8_3.

PMID:
29484586
42.

Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer.

Gipson BJ, Robbins HA, Fakhry C, D'Souza G.

Oral Oncol. 2018 Feb;77:52-56. doi: 10.1016/j.oraloncology.2017.12.008. Epub 2017 Dec 22.

43.

Reader performance in the ultrasonographic evaluation of oropharyngeal carcinoma.

Faraji F, Padilla ES, Blitz D, Wenderoth MB, Blanco RG, Kawamoto S, Sheth S, Hamper UM, Fakhry C.

Oral Oncol. 2018 Feb;77:105-110. doi: 10.1016/j.oraloncology.2017.12.012. Epub 2018 Jan 4.

PMID:
29362115
44.

Quality indicators of oropharyngeal cancer care in the elderly.

Gourin CG, Herbert RJ, Fakhry C, Quon H, Kang H, Kiess AP, Koch WM, Eisele DW, Frick KD.

Laryngoscope. 2018 Oct;128(10):2312-2319. doi: 10.1002/lary.27050. Epub 2017 Dec 15.

PMID:
29243261
45.

Oral sampling methods are associated with differences in immune marker concentrations.

Fakhry C, Qeadan F, Gilman RH, Yori P, Kosek M, Patterson N, Eisele DW, Gourin CG, Chitguppi C, Marks M, Gravitt P.

Laryngoscope. 2018 Jun;128(6):E214-E221. doi: 10.1002/lary.27002. Epub 2017 Nov 24.

46.

Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.

Quon H, Hui X, Cheng Z, Robertson S, Peng L, Bowers M, Moore J, Choflet A, Thompson A, Muse M, Kiess A, Page B, Fakhry C, Gourin C, O'Hare J, Graham P, Szczesniak M, Maclean J, Cook I, McNutt T.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1271-1278. doi: 10.1016/j.ijrobp.2017.08.004. Epub 2017 Aug 12.

PMID:
29165287
47.

Imbalance Between Clinical and Pathologic Staging in the Updated American Joint Commission on Cancer Staging System for Human Papillomavirus-Positive Oropharyngeal Cancer.

Fakhry C, Zevallos JP, Eisele DW.

J Clin Oncol. 2018 Jan 20;36(3):217-219. doi: 10.1200/JCO.2017.75.2063. Epub 2017 Nov 21. No abstract available.

PMID:
29161205
48.

Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.

D'Souza G, McNeel TS, Fakhry C.

Ann Oncol. 2017 Dec 1;28(12):3065-3069. doi: 10.1093/annonc/mdx535.

49.

Treatment, survival, and costs of oropharyngeal cancer care in the elderly.

Gourin CG, Fakhry C, Quon H, Kang H, Kiess AP, Herbert RJ, Eisele DW, Frick KD.

Laryngoscope. 2018 May;128(5):1103-1112. doi: 10.1002/lary.26887. Epub 2017 Oct 8.

PMID:
28988469
50.

Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers.

Rao AD, Coquia S, De Jong R, Gourin C, Page B, Latronico D, Dah S, Su L, Clarke S, Schultz J, Rosati LM, Fakhry C, Wong J, DeWeese TL, Quon H, Ding K, Kiess A.

Radiother Oncol. 2018 Jan;126(1):96-99. doi: 10.1016/j.radonc.2017.09.017. Epub 2017 Oct 3.

Supplemental Content

Loading ...
Support Center